Ptc Therapeutics, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 52856 (Ptc Therapeutics, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
8
Package NDCs
8
Products
8
Active listings
0
Discontinued
3
Ingredients
0
Therapeutic classes
3
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 8 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| EMFLAZA deflazacort 36 mg/1 TABLET | 52856-0504-03 | — | On market | View → |
| EMFLAZA deflazacort 30 mg/1 TABLET | 52856-0503-03 | — | On market | View → |
| EMFLAZA deflazacort 18 mg/1 TABLET | 52856-0502-03 | — | On market | View → |
| EMFLAZA deflazacort 22.75 mg/mL SUSPENSION | 52856-0505-22 | — | On market | View → |
| EMFLAZA deflazacort 6 mg/1 TABLET | 52856-0501-01 | — | On market | View → |
| KEBILIDI eladocagene exuparvovec-tneq 560000000000 {GC}/mL SUSPENSION | 52856-0601-01 | — | On market | View → |
| Sephience sepiapterin 250 mg/1 POWDER | 52856-0201-03 | — | On market | View → |
| Sephience sepiapterin 1000 mg/1 POWDER | 52856-0301-03 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.